Corrigendum to "MALAT-1: LncRNA ruling miR-182/PIG-C/mesothelin triad in triple negative breast cancer" [Pathol. Res. Pract. 216 (2020) 153274].

Autor: Barsoum FS; Molecular Pharmacology Research Group, Department of Pharmacology and Toxicology, Faculty of Pharmacy and Biotechnology, German University in Cairo, Egypt., Armanious M; Molecular Pharmacology Research Group, Department of Pharmacology and Toxicology, Faculty of Pharmacy and Biotechnology, German University in Cairo, Egypt., Awad AS; Molecular Pharmacology Research Group, Department of Pharmacology and Toxicology, Faculty of Pharmacy and Biotechnology, German University in Cairo, Egypt., Hussein NH; Molecular Pharmacology Research Group, Department of Pharmacology and Toxicology, Faculty of Pharmacy and Biotechnology, German University in Cairo, Egypt., Eissa RA; Department of Surgery, Ain Shams University, Egypt., El Tayebi HM; Molecular Pharmacology Research Group, Department of Pharmacology and Toxicology, Faculty of Pharmacy and Biotechnology, German University in Cairo, Egypt. Electronic address: Hend.saber@guc.edu.eg.

Publikováno v: Pathology, research and practice [Pathol Res Pract] 2023 Nov; Vol. 251, pp. 154834. Date of Electronic Publication: 2023 Oct 10.